Resveratrol attenuates early brain injury after subarachnoid hemorrhage through inhibition of NF-κB-dependent inflammatory/MMP-9 pathway

CNS Neuroscience and Therapeutics

Volumn 20, Issue 2, 2014, Pages 182-185

  Shao, An Wen ^a   Wu, Hai Jian ^a   Chen, Sheng ^a   Ammar, Al baadani ^a   Zhang, Jian Min ^a   Hong, Yuan ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CLAUDIN 5; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LAMIN B; MESSENGER RNA; PROTEIN ZO1; RESVERATROL; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN INJURY; DOWN REGULATION; LETTER; NONHUMAN; PROTEIN EXPRESSION; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; BRAIN INJURIES; DISEASE MODELS, ANIMAL; MATRIX METALLOPROTEINASE 9; NEOPLASM PROTEINS; NEUROLOGIC EXAMINATION; NF-KAPPA B; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; SUBARACHNOID HEMORRHAGE;

EID: 84892516850     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12194     Document Type: Letter

References (10)

1. Macdonald RL, Kassell NF, Mayer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008;39:3015-3021.
2. Sakata Y, Zhuang H, Kwansa H, Koehler RC, Doré S. Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp Neurol 2010;224:325-329.
3. Ates O, Cayli S, Altinoz E, et al. Neuroprotection by resveratrol against traumatic brain injury in rats. Mol Cell Biochem 2007;294:137-144.
4. Liu C, Shi Z, Fan L, Zhang C, Wang K, Wang B. Resveratrol improves neuron protection and functional recovery in rat model of spinal cord injury. Brain Res 2011;16:100-109.
5. Kumar A, Sharma SS. NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy. Biochem Biophys Res Commun 2010;394:360-365.
6. Lee WR, Chung CL, Hsiao CJ, et al. Suppression of matrix metalloproteinase-9 expression by andrographolide in human monocytic THP-1 cells via inhibition of NF-kappaB activation. Phytomedicine 2012;15:270-277.
7. Karaoglan A, Akdemir O, Barut S, et al. The effects of resveratrol on vasospasm after experimental subarachnoidal hemorrhage in rats. Surg Neurol 2008;70:337-343.
8. Feiler S, Plesnila N, Thal SC, Zausinger S, Schöller K. Contribution of matrix metalloproteinase-9 to cerebral edema and functional outcome following experimental subarachnoid hemorrhage. Cerebrovasc Dis 2011;32:289-295.
9. Zhong LM, Zong Y, Sun L, et al. Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells. PLoS ONE 2012;7:e32195.
10. Potnis PA, Dutta DK, Wood SC. Toll-like receptor 4 signaling pathway mediates proinflammatory immune response to cobalt-alloy particles. Cell Immunol 2013;282:53-65.